SQM Reports Earnings for the Nine Months Ended September 30, 2026
Financials
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026.
Commission File Number 33-65728
CHEMICAL AND MINING COMPANY OF CHILE INC.
(Translation of registrant’s name into English)
El Trovador 4285, Santiago, Chile (562) 2425-2000
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F:_X_ Form 40-F
For Immediate Release SQM REPORTS EARNINGS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2026 |
| Highlights |
| •SQM reported total revenues for the nine months ended September 30, 2026 of US$6,340.5 million compared to total revenues of US$3,252.4 million for the same period last year. |
| •Net income for the nine months ended September 30, 2026 of US$1,569.0 million or US$5.49 per share, compared to US$404.4 million or US$1.42 per share for the same period last year. |
| •Positive year-over-year (YoY) sales volume growth in lithium and iodine. |
| •Higher realized prices across our main business lines YoY. |
| •Strong underlying demand fundamentals in lithium and iodine markets. |
| SQM will hold a conference call to discuss these results on Wednesday, November 18, 2026 at 10:00am EST (12:00pm Chile time). |
| Participant Call link: register-conf.media-server.com/… |
| Webcast: https://edge.media-server.com/mmc/p/nkvkz6ne |
Santiago, Chile - November 17, 2026 - Sociedad Química y Minera de Chile S.A. (SQM) (NYSE: SQM; Santiago Stock Exchange: SQM-B, SQM-A) reported today net income for the nine months ended September 30, 2026, of US$1,569.0 million or US$5.49 per share, an increase of 288.0% compared to US$404.4 million or US$1.42 per share reported for the same period last year.
Gross profit(1) reached US$3,002.3 million (47.4% of revenues) for the nine months ended September 30, 2026, 233.6% higher than US$900.0 million (27.7% of revenues) recorded for the nine months ended September 30, 2025. Revenues totaled US$6,340.5 million for the nine months ended September 30, 2026, representing an increase of 95.0% compared to US$3,252.4 million reported for the nine months ended September 30, 2025.
The Company also announced net income for the third quarter of 2026 of US$544.2 million or US$1.91 per share, an increase of 205.0% compared to US$178.4 million or US$0.62 per share for the third quarter of 2025. Gross profit for the third quarter of 2026 reached US$963.8 million, 179.6% higher than the US$344.7 million reported for the third quarter of 2025. Revenues totaled US$2,112.0 million for the second quarter of 2025, an increase of 80.0% compared to US$1,173.0 million for the third quarter of 2025.
SQM’s Chief Executive Officer, Ricardo Ramos, stated, “I am pleased to announce SQM Group’s third-quarter results. We continued to deliver solid performance across our main business lines, with positive year-over-year results. Despite evolving market conditions, we remain confident in the fundamentals of our businesses and in the opportunities we see across our key markets.”
He added, “In lithium, we continue to see encouraging demand trends and remain confident in the long-term growth prospects of the market. Although lithium market prices have significantly declined since the peak observed during the second quarter, we continue to see strong appetite for lithium, supported not only by electric vehicle adoption but also by increasing lithium content in vehicles, the expansion of markets beyond China and the growing contribution of battery energy storage systems. We estimate that global lithium demand could grow by approximately 30% in 2026, and expect the market could surpass 3 million metric tons by 2030. These developments reinforce our confidence in the long-term fundamentals of the lithium market and our ability to participate in its continued growth.”
Mr. Ramos continued, “Moving to iodine, we once again delivered solid commercial results, supported by healthy market demand and favorable pricing conditions. Demand for iodine and its derivatives continues to be driven primarily by X-ray contrast media, and we believe the market could continue growing at an attractive pace in 2027. We remain focused on strengthening our position as a reliable supplier while advancing our operational efficiency and production capabilities.”
The CEO added, “The Specialty Plant Nutrition business also continued to demonstrate good commercial activity during the third quarter. We saw strong sales across our traditional markets, including the United States, Mexico and Spain. However, higher fertilizer prices have led some farmers to moderate their purchasing activity, prompting us to adjust our full-year sales volume growth outlook to approximately 5%. Meanwhile, prices have continued to show a positive trend.
| SQM S.A. 3Q2026 Earnings release | 1 |
We are also closely monitoring the potential impact of the El Niño phenomenon on our sales volumes in markets along the Pacific coast.”
Mr. Ramos concluded, “Overall, we remain focused on delivering solid operating and commercial performance, strengthening our competitive position and capturing the long-term opportunities across our main businesses.”
SQM Group
In October, we launched SQM Group, the same company our investors know as SQM, now with a renewed identity and a clear brand architecture for all of our businesses.
As part of SQM Group, we renamed our divisions to better reflect our businesses, organizing our five business lines into three divisions:
- Novandino Division: our lithium operations from the Salar de Atacama, Chile, to the world, carried out through our partnership with Codelco.
- SQM International Lithium Division: our lithium operations and project development in Australia and other countries.
- SQM Division: our iodine, plant nutrition, industrial chemicals businesses and metallic exploration.
SQM Group serves as the corporate umbrella for our divisions and brings them under a single set of corporate values. Excellence, safety, integrity and sustainability are at the core of everything we do, with a long-term view and innovation built into all of our solutions. This new chapter reflects what has always defined us: transforming natural resources into solutions for the human progress.
Sustainability
In October, SQM was certified under ISO 37301, the international standard for compliance management systems. This certification confirms that our compliance and control systems are aligned with international best practices and reinforces our culture of integrity, one of the corporate values that guide all of our businesses. It is also part of our ongoing commitment to strong corporate governance and sustainable business practices.
| SQM S.A. 3Q2026 Earnings release | 2 |
Segment Analysis
Lithium and Derivatives
Revenues for lithium and derivatives totaled US$4,481.8 million during the nine months ended September 30, 2026, an increase of 188.8% compared to US$1,551.8 million recorded for the nine months ended September 30, 2025.
Revenues for lithium and derivatives totaled US$1,517.0 million during the third quarter of 2026, an increase of 151.3% compared to US$603.7 million recorded for the third quarter of last year.
Gross profit(1) for the Lithium and Derivatives segment accounted for 79% of SQM’s consolidated gross profit for the nine months ended September 30, 2026.
Lithium and Derivatives Sales Volumes and Revenues:
| 9M2026 | 9M2025 | 2026/2025 | |||
| Lithium and Derivatives | Th. MT* | 232.3 | 181.0 | 51.3 | 28 % |
| Lithium and Derivatives Total Revenues | MUS$ | 4,481.8 | 1,551.8 | 2,930.0 | 189 % |
| *Note: Total sales volumes of Lithium Carbonate Equivalent (LCE) for the International Lithium Division for the nine months ended September 30, 2026 were approximately 20.4 th. MT, using a conversion factor for Spodumene Concentrate of 6.74x. | |||||
| Novandino Division | 9M2026 | 9M2025 | 2026/2025 | ||
| Lithium and Derivatives | Th. MT | 211.5 | 167.0 | 44.6 | 27 % |
| Lithium and Derivatives Revenues | MUS$ | 4,201.3 | 1,477.6 | 2,723.7 | 184 % |
| International Lithium Division (**) | 9M2026 | 9M2025 | 2026/2025 | ||
| Spodumene Concentrate (SC6) | Th. MT | 114.6 | 89.2 | 25.4 | 28 % |
| Lithium and Derivatives | Th. MT | 3.8 | 0.8 | 3.0 | 377 % |
| Lithium and Derivatives Revenues | MUS$ | 280.4 | 74.1 | 206.4 | 279 % |
| **Reflects SQM’s attributable portion only. |
| 3Q2026 | 3Q2025 | 2026/2025 | |||
| Lithium and Derivatives | Th. MT* | 78.9 | 72.9 | 6.0 | 8 % |
| Lithium and Derivatives Total Revenues | MUS$ | 1,517.0 | 603.7 | 913.3 | 151 % |
| *Note: Total sales volumes of Lithium Carbonate Equivalent (LCE) for the International Lithium Division for the third quarter of 2026 were approximately 5.5 th. MT, using a conversion factor for Spodumene Concentrate of 6.74x. | |||||
| Novandino | 3Q2026 | 3Q2025 | 2026/2025 | ||
| Lithium and Derivatives | Th. MT | 73.3 | 62.9 | 10.3 | 16 % |
| Lithium and Derivatives Revenues | MUS$ | 1,436.7 | 552.1 | 884.5 | 160 % |
| International Lithium Division (**) | 3Q2026 | 3Q2025 | 2026/2025 | ||
| Spodumene Concentrate (SC6) | Th. MT | 28.5 | 61.9 | (33.4) | (54)% |
| Lithium and Derivatives | Th. MT | 1.4 | 0.8 | 0.6 | 76 % |
| Lithium and Derivatives Revenues | MUS$ | 80.3 | 51.5 | 28.9 | 56 % |
**Reflects SQM’s attributable portion only.
| SQM S.A. 3Q2026 Earnings release | 1 |
During the third quarter, we observed a shift in lithium price trends, with our average realized lithium sales price decreasing by 10% quarter-over-quarter, while spodumene prices remained relatively flat. However, in recent weeks, we have observed a significant decline in market prices, which suggests that our average realized lithium sales price in the fourth quarter could be substantially lower than in the third quarter.
We continue to see encouraging underlying demand trends. Although electric vehicle sales in China have experienced some moderation, the total lithium content in EVs has continued to increase, reflecting the evolution of the market toward vehicles with higher lithium requirements. Furthermore, Chinese automotive exports have continued to grow strongly, particularly to markets outside China, including South Korea, Brazil, Australia and India. At the same time, EV sales in Europe continue to demonstrate solid growth. Together, these trends are supporting global EV adoption beyond the Chinese domestic market.
Looking ahead, we expect additional sources of demand to contribute to market growth, including the electrification of heavy-duty trucks and the continued deployment of battery energy storage systems (BESS), particularly for behind-the-meter applications.
Overall, we remain confident in the long-term fundamentals supporting lithium demand and the continued growth of the market.
•Novandino Division:
During the third quarter, sales volumes for Novandino reached approximately 73.3 thousand metric tons of lithium products, representing a 16% increase compared to the same period last year, and a 3% decrease compared to the record levels reported in the second quarter of 2026.
Operations and commercial activity continued as expected during the quarter, with ongoing expansion projects progressing according to schedule.
The average realized lithium sales price for Novandino during the third quarter was approximately US$19.6 per kilogram, representing a 10% decrease compared to the second quarter of 2026 and a 123% increase compared to the average realized price in the same period last year.
•SQM International Lithium Division:
During the third quarter, sales volumes in Australia reached approximately 5.5 thousand metric tons of LCE. Although volumes were lower compared to both the same period last year and the previous quarter, this primarily reflects the timing of sales, with year-to-date sales volumes remaining 47% above the same period in 2025. Looking ahead, we expect sales volumes to increase during the fourth quarter, allowing us to close 2026 with full-year sales volumes approximately 20% above 2025 levels.
Production continues to progress well, with current annual production reaching approximately 175 - 185 thousand metric tons of spodumene concentrate (SC6) attributable to SQM. We have also commenced the expansion phase of the mining and concentrator plant at Mount Holland, which is expected to progressively increase production capacity to approximately 350 thousand metric tons of spodumene concentrate (SC6) attributable to SQM by 2030 - 2031.
Our average realized spodumene sales price during the third quarter reached approximately US$2,036 per metric ton of spodumene concentrate (SC6), remaining relatively flat compared to the second quarter of 2026, and representing an increase of 185% year-over-year.
Specialty Plant Nutrition (SPN)
Revenues from our Specialty Plant Nutrition business line for the nine months ended September 30, 2026 totaled US$831.0 million, an increase of 13.5% when compared to US$732.4 million reported for the nine months ended September 30, 2025.
Revenues from our Specialty Plant Nutrition business line for the third quarter of 2026 totaled US$269.1 million, an increase of 4% when compared to US$259.8 million reported for the third quarter of 2025.
| SQM S.A. 3Q2026 Earnings release | 2 |
Gross profit(1) for SPN segment accounted for 5% of SQM’s consolidated gross profit for the nine months ended September 30, 2026.
Specialty Plant Nutrition Sales Volumes and Revenues:
| 9M2026 | 9M2025 | 2026/2025 | |||
| Specialty Plant Nutrition Total Volumes | Th. MT | 775.8 | 759.7 | 16.1 | 2 % |
| Sodium Nitrate | Th. MT | 6.2 | 7.2 | (1.0) | (14)% |
| Potassium Nitrate | Th. MT | 408.9 | 394.7 | 14.2 | 4% |
| Specialty Blends | Th. MT | 211.2 | 226.8 | (15.6) | (7)% |
| Other specialty plant nutrients (*) | Th. MT | 149.4 | 131.0 | 18.5 | 14% |
| Specialty Plant Nutrition Revenues | MUS$ | 831.0 | 732.4 | 98.6 | 13 % |
| 3Q2026 | 3Q2025 | 2026/2025 | |||
| Specialty Plant Nutrition Total Volumes | Th. MT | 240.5 | 277.8 | (37.2) | (13)% |
| Sodium Nitrate | Th. MT | 1.3 | 2.1 | (0.8) | (37)% |
| Potassium Nitrate | Th. MT | 114.9 | 127.9 | (13.1) | (10)% |
| Specialty Blends | Th. MT | 79.5 | 103.6 | (24.1) | (23)% |
| Other specialty plant nutrients (*) | Th. MT | 44.8 | 44.1 | 0.7 | 2% |
| Specialty Plant Nutrition Revenues | MUS$ | 269.1 | 259.8 | 9.2 | 4 % |
During the third quarter, fertilizer prices continued to increase, and our main products followed this trend. Higher prices have led some farmers to moderate their purchases of potash-based products, including potassium nitrate. In light of these market dynamics, we are revising our full-year 2026 sales volume growth outlook for this business line to approximately 5%, compared to our previous expectation of approximately 10% growth over 2025.
The increase in sales volumes and prices during the quarter was primarily driven by supply constraints in certain markets, particularly lower product availability from China, as well as supply disruptions associated with the conflict in the Middle East. These conditions allowed us to increase sales volumes in non-traditional markets, such as Eastern Europe and Africa.
We also observed strong commercial activity in the United States, Mexico and Spain.
Looking ahead, we continue to monitor the potential impact of higher-than-expected rainfall associated with the El Niño phenomenon along the Pacific coast. These weather conditions could affect agricultural activity and lead to lower fertilizer purchases by customers in these markets during the coming months.
Our average realized price for this business line reached US$1,119 per metric ton, representing a 20% increase compared to the same period last year and a 5% increase quarter-over-quarter. Based on current market dynamics, we expect prices to remain broadly at current levels through the remainder of the year.
Iodine and Derivatives
Revenues from sales of iodine and derivatives during the nine months of 2026 totaled US$840.1 million, an increase 9.0% of compared to US$770.8 million reported for the nine months of 2025.
Revenues from sales of iodine and derivatives during the third quarter of 2026, totaled US$262.0 million, an increase of 7.1% compared to US$244.6 million reported for the third quarter of 2025.
Gross profit(1) for the Iodine and Derivatives segment accounted for 15% of SQM’s consolidated gross profit for the nine months ended September 30, 2026.
| SQM S.A. 3Q2026 Earnings release | 3 |
Iodine and Derivative Sales Volumes and Revenues:
| 9M2026 | 9M2025 | 2026/2025 | |||
| Iodine and Derivatives | Th. MT | 11.5 | 10.8 | 0.7 | 7% |
| Iodine and Derivatives Revenues | MUS$ | 840.1 | 770.8 | 69.3 | 9% |
| 3Q2026 | 3Q2025 | 2026/2025 | |||
| Iodine and Derivatives | Th. MT | 3.6 | 3.4 | 0.2 | 5% |
| Iodine and Derivatives Revenues | MUS$ | 262.0 | 244.6 | 17.5 | 7% |
Commercial activity for iodine and its derivatives remained strong during the third quarter. Although sales volumes declined seasonally compared to the first half of the year, they increased by 5% compared to the same period in 2025.
We expect demand to remain robust and estimate that global iodine demand could grow over 3% in 2027 compared to 2026, mainly driven by continued demand for X-ray contrast media.
During the third quarter of 2026, our average realized iodine price reached US$73 per kilogram, representing a 2% increase year-over-year and a slight decrease quarter-over-quarter due to customer mix. Based on current market dynamics, we believe prices could remain broadly stable, with the potential for a slight increase during the fourth quarter.
We continue to advance our expansion plans and improve operational efficiency, optimizing our product mix while maintaining our position as a reliable supplier to our customers. Our current effective annual production is estimated to exceed 16,000 metric tons of iodine this year. Looking ahead, subject to additional investments and market requirements, we believe there could be potential to increase our annual production capacity to approximately 20,000 metric tons in the coming years.
Potassium
Potassium revenues for the nine months ended September 30, 2026, totaled US$106.6 million, a decrease of 8.6% when compared to revenues reported during the nine months ended September 30, 2025, which totaled US$116.7 million.
Potassium revenues for the third quarter of 2026 totaled US$31.0 million, lower than revenues reported during the third quarter of 2025, which totaled US$33.8 million, representing a 8.2% decrease.
Gross profit(1) for Potassium segment accounted for 0.5% of SQM’s consolidated gross profit for the nine months ended September 30, 2026.
Potassium Sales Volumes and Revenues:
| 9M2026 | 9M2025 | 2026/2025 | |||
| Potassium | Th. MT | 196.6 | 252.8 | (56.3) | (22)% |
| Potassium Revenues | MUS$ | 106.6 | 116.7 | (10.1) | (9)% |
| 3Q2026 | 3Q2025 | 2026/2025 | |||
| Potassium | Th. MT | 47.6 | 66.8 | (19.1) | (29)% |
| Potassium Revenues | MUS$ | 31.0 | 33.8 | (2.8) | (8)% |
As anticipated, potassium sales volumes continued to decline as we progressively shifted our operations at the Salar de Atacama toward prioritizing lithium extraction. Sales volumes for this business line decreased by 29% in the third quarter of 2026 compared to the same period last year.
| SQM S.A. 3Q2026 Earnings release | 4 |
Industrial Chemicals
Industrial chemicals revenues for the nine months ended September 30, 2026 reached US$60.6 million, 6% higher than US$57.1 million recorded for the nine months of 2025.
Industrial chemicals revenues for the third quarter of 2026 reached US$22.2 million, a 16.6% increase compared to US$19.1 million recorded for the third quarter of 2025.
Gross profit(1) for the Industrial Chemicals segment accounted for 0.8% of SQM’s consolidated gross profit for the nine months ended September 30, 2026.
Industrial Chemicals Sales Volumes and Revenues:
| 9M2026 | 9M2025 | 2026/2025 | |||
| Industrial Nitrates | Th. MT | 41.2 | 38.6 | 2.7 | 7% |
| Industrial Chemicals Revenues | MUS$ | 60.6 | 57.1 | 3.5 | 6% |
| 3Q2026 | 3Q2025 | 2026/2025 | |||
| Industrial Nitrates | Th. MT | 14.8 | 12.5 | 2.3 | 19% |
| Industrial Chemicals Revenues | MUS$ | 22.2 | 19.1 | 3.2 | 17% |
During the third quarter, we observed increased commercial activity, partly driven by internal commercial decisions that are expected to result in lower sales volumes during the fourth quarter. Overall, we expect sales volumes in the second half of 2026 to remain broadly in line with those recorded during the first half of the year.
Looking ahead to 2027, we expect this business line to continue following a trend similar to that observed in recent years, with modest and steady year-over-year volume growth and relatively stable market prices.
Other Commodity Fertilizers & Other Income
Revenues from sales of other commodity fertilizers and other income reached US$20.3 million for the nine months ended September 30, 2026, a decrease compared to US$23.6 million for the nine months ended September 30, 2025.
Financial Information
Cost of Sales
Cost of sales amounted to US$3,338.2 million for the nine months ended September 30, 2026, an increase of 42% compared to US$2,352.4 million for the same period in 2025.
Administrative Expenses
Administrative expenses totaled US$152.8 million (2.4% of revenues) for the nine months ended September 30, 2026, compared to US$140.2 million (4.3% of revenues) for the nine months ended September 30, 2025.
Financial Indicators
Net Financial Expenses
Net financial expenses for the nine months ended September 30, 2026 totaled US$56.3 million, compared to net financial expenses of US$84.0 million for the nine months ended September 30, 2025.
| SQM S.A. 3Q2026 Earnings release | 5 |
Income Tax Expense
Income tax expense for the nine months ended September 30, 2026, totaled US$1,081.4 million, compared to US$216.6 million for the same period in 2025.
Adjusted EBITDA(2)
Adjusted EBITDA for the nine months ended September 30, 2026, reached US$3,189.7 million (Adjusted EBITDA margin of 50.3%), compared to US$1,067.5 million (Adjusted EBITDA margin of 32.8%) for the nine months ended September 30, 2025.
Notes:
(1) A significant portion of SQM’s cost of sales are costs related to common productive processes (mining, crushing, leaching, etc.) which are distributed among the different final products. To estimate gross profit by business line in both periods covered by this release, the Company employed similar criteria on the allocation of common costs to the different business areas. This gross profit distribution should be used only as a general and approximated reference of the margins by business line.
(2) Adjusted EBITDA = EBITDA – Other income – Other gains (losses) - Share of Profit of associates and joint ventures accounted for using the equity method + Other expenses by function + Net impairment gains on reversal (losses) of financial assets – Finance income – Currency differences. EBITDA = Profit for the Period + Depreciation and Amortization Expenses + Finance Costs + Income Tax. Adjusted EBITDA margin = Adjusted EBITDA/revenues. We have included adjusted EBITDA to provide investors with a supplemental measure of our operating performance. We believe adjusted EBITDA is important supplemental measure of operating performance because it eliminates items that have less bearing on our operating performance and thus highlights trends in our core business that may not otherwise be apparent when relying solely on IFRS financial measures. Adjusted EBITDA has important limitations as analytical tool. For example, adjusted EBITDA does not reflect (a) our cash expenditures, or future requirements for capital expenditures or contractual commitments; (b) changes in, or cash requirements for, our working capital needs; (c) the significant interest expense, or the cash requirements necessary to service interest or principal payments, on our debt; and (d) tax payments. Although we consider the items excluded in the calculation of non-IFRS measures to be less relevant to evaluate our performance, some of these items may continue to take place and accordingly may reduce the cash available to us.
We believe that the presentation of the non-IFRS financial measures described above is appropriate. However, these non-IFRS measures have important limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under IFRS. Because of these limitations, we primarily rely on our results as reported in accordance with IFRS and use EBITDA and adjusted EBITDA only supplementally.
| SQM S.A. 3Q2026 Earnings release | 6 |
EBITDA Reconciliation
| For the 3rd quarter | For the nine months ended September 30 | |||
| (US$ millions) | 2026 | 2025 | 2026 | 2025 |
| Profit for the Period | 596.5 | 180.0 | 1,718.6 | 407.8 |
| (+) Depreciation and amortization expenses | 122.7 | 107.7 | 340.2 | 307.8 |
| (+) Finance costs | 57.4 | 47.4 | 167.3 | 146.7 |
| (+) Income tax expense | 343.1 | 85.6 | 1,081.4 | 216.6 |
| EBITDA | 1,119.6 | 420.7 | 3,307.4 | 1,078.7 |
| (-) Other income | 23.2 | 1.4 | 35.5 | 5.8 |
| (-) Other gains (losses) | 50.0 | — | 49.8 | (1.0) |
| (-) Share of Profit of associates and joint ventures accounted for using the equity method | (6.8) | 2.7 | (8.1) | 3.3 |
| (+) Other Expenses | (34.9) | (8.8) | (60.0) | (61.8) |
| (+) Impairment of financial assets and reversal of impairment losses | 0.3 | 0.3 | (0.5) | 0.4 |
| (-) Finance income | 49.9 | 22.0 | 111.0 | 62.7 |
| (-) Foreign currency translation differences | 3.2 | (0.1) | (10.0) | 1.9 |
| Adjusted EBITDA* | 1,034.9 | 403.2 | 3,189.7 | 1,067.5 |
| *2025 figures related to cost of goods sold, other income (expenses), share of profit of associates and JV were updated due to different accounting methods applied for this period. |
| SQM S.A. 3Q2026 Earnings release | 7 |
Consolidated Statement of Financial Position
| As of Sept. 30 | As of Dec. 31 | |
| (US$ millions) | 2026 | 2025 |
| Total Current Assets | 8,388.0 | 5,780.5 |
| Cash and cash equivalents | 2,692.2 | 1,750.3 |
| Other current financial assets | 2,342.3 | 976.6 |
| Accounts receivable (1) | 1,074.5 | 685.9 |
| Inventory | 1,942.1 | 1,803.5 |
| Others | 337.0 | 564.2 |
| Total Non-current Assets | 8,920.0 | 8,724.5 |
| Other non-current financial assets | 53.7 | 76.2 |
| Investments in related companies | 637.7 | 631.2 |
| Property, plant and equipment | 5,004.2 | 4,839.5 |
| Other Non-current Assets | 3,224.4 | 3,177.5 |
| Total Assets | 17,308.1 | 14,505.0 |
| Total Current Liabilities | 3,129.2 | 1,768.8 |
| Short-term debt | 764.6 | 470.8 |
| Others | 2,364.7 | 1,298.1 |
| Total Long-Term Liabilities | 5,113.2 | 4,682.2 |
| Long-term debt | 4,749.6 | 4,220.6 |
| Others | 363.6 | 461.7 |
| Shareholders’ Equity before Minority Interest | 6,697.8 | 5,691.3 |
| Minority Interest | 2,367.8 | 2,362.6 |
| Total Shareholders’ Equity | 9,065.6 | 8,053.9 |
| Total Liabilities & Shareholders’ Equity | 17,308.1 | 14,505.0 |
| Liquidity (2) | 2.68 | 3.27 |
__________________________________________
(1)Accounts receivable + accounts receivable from related companies
(2)Current assets / current liabilities
| SQM S.A. 3Q2026 Earnings release | 8 |
Consolidated Statement of Income
| For the 3rd quarter | For the nine months ended September 30 | |||
| (US$ millions) | 2026 | 2025 | 2026 | 2025 |
| Revenues | 2,112.0 | 1,173.0 | 6,340.5 | 3,252.4 |
| Lithium and Derivatives | 1,517.0 | 603.7 | 4,481.8 | 1,551.8 |
| Specialty Plant Nutrition (1) | 269.1 | 259.8 | 831.0 | 732.4 |
| Iodine and Derivatives | 262.0 | 244.6 | 840.1 | 770.8 |
| Potassium | 31.0 | 33.8 | 106.6 | 116.7 |
| Industrial Chemicals | 22.2 | 19.1 | 60.6 | 57.1 |
| Other Income | 10.7 | 12.1 | 20.3 | 23.6 |
| Cost of Sales | (1,148.3) | (828.3) | (3,338.2) | (2,352.4) |
| Gross Profit | 963.8 | 344.7 | 3,002.3 | 900.0 |
| Administrative Expenses | (51.5) | (49.3) | (152.8) | (140.2) |
| Financial Expenses | (57.4) | (47.4) | (167.3) | (146.7) |
| Financial Income | 49.9 | 22.0 | 111.0 | 62.7 |
| Exchange Difference | 3.2 | (0.1) | (10.0) | 1.9 |
| Other | 31.6 | (4.4) | 16.7 | (53.4) |
| Income Before Taxes | 939.6 | 265.6 | 2,800.0 | 624.3 |
| Income Tax | (343.1) | (85.6) | (1,081.4) | (216.6) |
| Net Income before minority interest | 596.5 | 180.0 | 1,718.6 | 407.8 |
| Minority Interest | (52.2) | (1.6) | (149.6) | (3.4) |
| Net Income | 544.2 | 178.4 | 1,569.0 | 404.4 |
| Net Income per Share (US$) | 1.91 | 0.62 | 5.49 | 1.42 |
| *2025 figures related to cost of goods sold, other income (expenses), share of profit of associates and JV were updated due to different accounting methods applied for this period. |
__________________________________________
(1)Includes other specialty fertilizers
| SQM S.A. 3Q2026 Earnings release | 9 |
About SQM
SQM is a global company that is listed on the New York Stock Exchange and the Santiago Stock Exchange (NYSE: SQM; Santiago Stock Exchange: SQM-B, SQM-A). SQM develops and produces diverse products for several industries essential for human progress, such as health, nutrition, renewable energy and technology through innovation and technological development. We aim to maintain our leading world position in the lithium, iodine, and potassium nitrate markets.
For further information, contact:
Gerardo Illanes / [email protected]
Isabel Bendeck / [email protected]
Megan Suitor / [email protected]
For media inquiries, contact:
Novandino: Ignacia Lopez / [email protected]
Lithium Division: Gonzalo Colazo / [email protected]
SQM Division: Carolina Guzman / [email protected]
Cautionary Note Regarding Forward-Looking Statements
This news release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: “anticipate,” “plan,” “believe,” “estimate,” “expect,” “strategy,” “should,” “will” and similar references to future periods. Examples of forward-looking statements include, among others, statements we make concerning the development of Salar Futuro Project, Company’s capital expenditures, financing sources, Sustainable Development Plan, business and demand outlook, future economic performance, anticipated sales volumes and sales prices, profitability, revenues, expenses, or other financial items, anticipated cost synergies and product or service line growth.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are estimates that reflect the best judgment of SQM management based on currently available information. Because forward-looking statements relate to the future, they involve a number of risks, uncertainties and other factors that are outside of our control and could cause actual results to differ materially from those stated in such statements, including our ability to successfully implement the Sustainable Development Plan. Therefore, you should not rely on any of these forward-looking statements. Readers are referred to the documents filed by SQM with the United States Securities and Exchange Commission, including the most recent annual report on Form 20-F, which identifies other important risk factors that could cause actual results to differ from those contained in the forward-looking statements. All forward-looking statements are based on information available to SQM on the date hereof and SQM assumes no obligation to update such statements, whether as a result of new information, future developments or otherwise, except as required by law.
| SQM S.A. 3Q2026 Earnings release | 10 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CHEMICAL AND MINING COMPANY OF CHILE INC. | |
| (Registrant) | |
| Date: November 17, 2026 | /s/ Gerardo Illanes |
| By: Gerardo Illanes | |
| CFO |
Persons who are to respond to the collection of information contained SEC 1815 (04-09) in this form are not required to respond unless the form displays currently valid OMB control number.